Abstract
Introduction/Background*To investigate the association between the presence of BRCA1/2 mutations and the chemotherapy response score (CRS) in patients with advanced stage high-grade serous ovarian cancer (HGSOC) undergoing neoadjuvant chemotherapy (NACT)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have